The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Cyberonics Inc.

  • CYBX
  • NASDAQ
  • Consumer Products
  • Latest 61.58
  • Currency US$
  • Change 0.33
  • Percent Change 0.539 %
  • Volume 25,795
  • Thu Apr 17, 2014 10:23 AM EDT NASDAQ data delayed 15 minutes.
  • Open 60.98
  • Previous Close 61.25
  • High 61.92
  • Low 60.83
  • Bidx2 61.64
  • Askx1 62.05
  • 52-week High02/14 73.52
  • 52-week Low04/26 42.49
  • Beta 0.458
  • Market Cap 1,661.43M
  • EPS 1.78
  • P/E 34.596
  • Forward P/E 25.41
  • PEG 1.80
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $275,500,000
  • Earnings $47,990,000
  • Return on Equity 20.15%

Cash Flow

  • Cash Flow --
  • Cash $91,600,000
  • Current Ratio 8.24

12 months ended Jan 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $269,180,000
  • Liabilities $28,930,000
  • Liabilities-to-Equity Ratio 0.12

Price Ratios

  • Price to Sales 6.03
  • Price to Book 6.92
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Feb 20 $0.49 Jun 4 $0.55
Surprises Feb 20 4.08% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 17, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Cyberonics, Inc. was founded to design, develop and market medical devices for the treatment of epilepsy and other debilitating neurological disorders using a therapy, vagus nerve stimulation. The company's initial target market is epilepsy, the world's second most prevalent neurological disorder, which is characterized by seizures. Vagus nerve stimulation with the Cyberonics NCP System was approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents with medically refractory partial onset seizures. (PRESS RELEASE)

Related Securities
Symbol Type Latest % Chg

Officers

  • Hugh M. Morrison Chairman of the Board of Direc
  • Daniel J. Moore President; Chief Executive Off
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

100 CYBERONICS BLVD
HOUSTON, TX
77058

Phone: (281)-228-7200
Fax: (281)-2189332

ir@cyberonics.com
www.cyberonics.com

Ideas & Discussion

Live Discussion of CYBX on StockTwits